Paul O'Brien to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Paul O'Brien has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.132
-
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
Score: 0.075
-
Molecular targets in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol. 2007 Jun; 8(3):239-51.
Score: 0.057